Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
With a market cap of 189.22B, Amgen(AMGN) trades at $352.50. The stock has a price-to-earnings ratio of 24.70 and currently yields dividends of 2.8%.
On 2026-06-15, Amgen(AMGN) stock moved within a range of $349.56 to $358.30. With shares now at $352.50, the stock is trading +0.8% above its intraday low and -1.6% below the session's peak.
Trading volume for Amgen(AMGN) stock has reached 4.3M, versus its average volume of 2.87M.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $391.29 and a low of $267.83.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $391.29 and a low of $267.83.
AMGN News
In recent trading, shares of Amgen Inc (Symbol: AMGN) have crossed above the average analyst 12-month target price of $242.67, changing hands for $243.12/share....
HBM Holdings Ltd. ( (HK:2142) ) has issued an announcement. HBM Holdings Limited has secured a significant legal victory in the United States, where a Delaware...
...
Analyst ratings
47%
of 36 ratingsMore AMGN News
Key Points Eli Lilly, Novo Nordisk, Amgen, Zealand, Structure Therapeutics shared their visions for the future of obesity medicine. Drugmakers pitched doctors...
The company argues that the drug's benefits continue to outweigh its risks for patients with a rare autoimmune disease. The request, submitted by Amgen and its...
Amgen AMGN is one of the several drug makers racing to develop an innovative weight-loss drug and take a share of the booming weight loss drug market. The globa...
Morgan Stanley analyst Terence Flynn raised the firm’s price target on Amgen (AMGN) to $340 from $332 and keeps an Equal Weight rating on the shares. The firm,...
Amgen (NASDAQ:AMGN) executives said the company’s first-quarter performance supports its view that 2026 can serve as a “springboard year,” with growth products...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.